These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4402038)

  • 1. Evidence for a new type of dopamine receptor stimulating agent.
    Corrodi H; Fuxe K; Ungerstedt U
    J Pharm Pharmacol; 1971 Dec; 23(12):989-91. PubMed ID: 4402038
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE
    Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for dopamine receptor stimulation by apomorphine.
    Andén NE; Rubenson A; Fuxe K; Hökfelt T
    J Pharm Pharmacol; 1967 Sep; 19(9):627-9. PubMed ID: 4383150
    [No Abstract]   [Full Text] [Related]  

  • 4. An ontogenic study on the effect of catecholamine receptor-stimulating agents on the turnover of noradrenaline and dopamine in the brain.
    Kellogg C; Wennerström G
    Brain Res; 1974 Oct; 79(3):451-64. PubMed ID: 4371328
    [No Abstract]   [Full Text] [Related]  

  • 5. ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors.
    Corrodi H; Farnebo LO; Fuxe K; Hamberger B; Ungerstedt U
    Eur J Pharmacol; 1972 Nov; 20(2):195-204. PubMed ID: 4651208
    [No Abstract]   [Full Text] [Related]  

  • 6. Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation.
    Fuxe K; Corrodi H; Hökfelt T; Lidbrink P; Ungerstedt U
    Med Biol; 1974 Apr; 52(2):121-32. PubMed ID: 4837435
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-endorphin induced akinesia in rats: effect of apomorhine and alpha-methyl-p-tyrosine and related modifications of dopamine turnover in the basal ganglia.
    Izumi K; Motomatsu T; Chrétien M
    Life Sci; 1977 Apr; 20(7):1149-55. PubMed ID: 557716
    [No Abstract]   [Full Text] [Related]  

  • 8. Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine.
    Rech RH; Borys HK; Moore KE
    J Pharmacol Exp Ther; 1966 Sep; 153(3):412-9. PubMed ID: 5922318
    [No Abstract]   [Full Text] [Related]  

  • 9. On the role of brain catecholamines in motor activity: experiments with inhibitors of synthesis and of monoamine oxidase.
    Svensson TH; Waldeck B
    Psychopharmacologia; 1970; 18(4):357-65. PubMed ID: 5491473
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis.
    Carlsson A; Engel J; Strömbom U; Svensson TH; Waldeck B
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(2):117-28. PubMed ID: 4278296
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioural evidence of dopamine receptor stimulation by piribedil (ET495) and its metabolite S584.
    Creese I
    Eur J Pharmacol; 1974 Sep; 28(1):55-8. PubMed ID: 4473347
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal of alpha-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine.
    Moore KE; Rech RH
    J Pharm Pharmacol; 1967 Jun; 19(6):405-7. PubMed ID: 4382374
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that methadone blocks dopamine receptors in the brain.
    Sasame HA; Perez-Cruet J; Di Chiara G; Tagliamonte A; Tagliamonte P; Gessa GL
    J Neurochem; 1972 Aug; 19(8):1953-7. PubMed ID: 4538006
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effects of reserpine and alpha-methyl-P-tyrosine on norepinephrine and dopamine induced behavioral activity.
    Geyer MA; Segal DS
    Psychopharmacologia; 1973 Mar; 29(2):131-40. PubMed ID: 4709837
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of dopamine and norepinephrine in the naloxone-induced abstinence of morphine-dependent mice.
    Maruyama Y; Takemori AE
    J Pharmacol Exp Ther; 1973 Jun; 185(3):602-8. PubMed ID: 4736512
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of ECT on dopaminergic and noradrenergic mechanisms. II. Effect on dopamine and noradrenaline concentrations and turnovers.
    Papeschi R; Randrup A; Munkvad I
    Psychopharmacologia; 1974 Feb; 35(2):159-68. PubMed ID: 4815115
    [No Abstract]   [Full Text] [Related]  

  • 18. Modification by methyltyrosine methylester (H 44-68) of the amphetamine-induced toxicity and brain catecholamine changes in developing mice.
    Alhava E
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):119-28. PubMed ID: 4741031
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of extracellular dopamine levels can be dissociated from suppression of exploratory behaviour in rats.
    Ståhle L; Ungerstedt U
    Acta Physiol Scand; 1987 Jul; 130(3):533-4. PubMed ID: 3630731
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression.
    Moore KE; Rech RH
    J Pharmacol Exp Ther; 1967 Apr; 156(1):70-5. PubMed ID: 6023602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.